BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 18243259)

  • 1. Detection of HIV antigen and cDNA among antibody-negative blood samples in Nigeria.
    Odaibo GN; Taiwo A; Aken'Ova YA; Olaleye DO
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):284-7. PubMed ID: 18243259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
    Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
    Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HIV-1 window period infection in blood donors using borderline anti-HIV results, HIV-1 proviral DNA PCR, and HIV-1 antigen test.
    Wongsena W; Kunakorn M; Tanprasert S; Petchclai B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S112-5. PubMed ID: 9347657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory strategic defense initiatives against transmission of human immune deficiency virus in blood and blood products.
    Ahmed SG
    Niger Postgrad Med J; 2003 Dec; 10(4):254-9. PubMed ID: 15045022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing risk of transfusion-associated AIDS as the pandemic spreads: experience in Maiduguri, Nigeria.
    Harry TO; Moses AE; Ola TO; Obi SO; Bajani MD
    J Trop Med Hyg; 1993 Apr; 96(2):131-3. PubMed ID: 8459487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV P24 antigen among HIV antibody seronegative blood donors in Osogbo Osun State, South Western Nigeria.
    Olowe OA; Mabayoje VO; Akanbi O; Adefioye OJ; Olowe RA; Fadeni EK; Oluremi AS; Opaleye OO
    Pathog Glob Health; 2016; 110(4-5):205-8. PubMed ID: 27386900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
    Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
    Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria--the question of safety of blood transfusion in Nigeria.
    Osaro E; Mohammed N; Zama I; Yakubu A; Dorcas I; Festus A; Kwaifa I; Sani I
    Pan Afr Med J; 2014; 18():174. PubMed ID: 25419301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrovirus and blood transfusion].
    Barrera JM; Ercilla MG; Gil BC
    Sangre (Barc); 1993 Jun; 38(3):187-92. PubMed ID: 8105545
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
    Malhotra R; Morgan DA
    Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The problems of indeterminate HIV results in blood transfusion services in Nigeria.
    Elemuwa CO; Bassey BE; Olaleye DO
    Trop Doct; 2005 Jul; 35(3):166-7. PubMed ID: 16105345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
    Malm K; von Sydow M; Andersson S
    Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV antigen test of blood donors].
    Knödler B; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():10-1. PubMed ID: 8374280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of testing and potential impact on HIV prevention in Nigeria.
    Odaibo GN; Donbraye E; Adewumi MO; Bakarey AS; Ibeh MA; Olaleye DO
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():131-5. PubMed ID: 18050787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comments to the manuscript; HIV in Mexican blood donors and estimated transfusional risk].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2008; 60(6):545-6; author reply 547. PubMed ID: 19378840
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress toward strengthening blood transfusion services--14 countries, 2003-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(47):1273-7. PubMed ID: 19037194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.
    Tagny CT; Mbanya D; Leballais L; Murphy E; Lefrère JJ; Laperche S
    Transfusion; 2011 Jan; 51(1):184-90. PubMed ID: 20663109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.